Marshall Wace’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-100
Closed -$7.9K 3252
2025
Q4
$7.9K Buy
+100
New +$7.84K ﹤0.01% 2871
2024
Q1
Sell
-89,700
Closed -$7.15M 2478
2023
Q4
$7.15M Buy
+89,700
New +$6.74M 0.01% 783

Other funds holding CL

Marshall Wace's CL Position: Q1 2026 in Review

Marshall Wace reduced its Colgate-Palmolive (CL) stake by 100% in Q1 2026, selling an estimated $94.8M and leaving 4,000 shares worth $341K. The position accounts for ﹤0.01% of the portfolio, ranked #2606.

Marshall Wace first reported a position in CL in Q1 2014 and has held it in 38 quarters since. The position peaked at $164M in Q4 2023. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Marshall Wace held 4,000 shares of Colgate-Palmolive worth $341K as of Q1 2026.
  • Marshall Wace sold 1,063,700 Colgate-Palmolive shares in Q1 2026, an estimated $94.8M.
  • Colgate-Palmolive made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #2606 holding.
  • Marshall Wace first reported a position in Colgate-Palmolive in Q1 2014 and has held it in 38 quarters since.
  • Marshall Wace's Colgate-Palmolive position peaked at $164M in Q4 2023.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.